King Pharmaceuticals
-
DURECT Announces Update on Remoxy®
DURECT Announces Update on Remoxy®
-
King Pharmaceuticals , Inc. KG Q1 2010 Earnings Call Transcript
Good morning, ladies and gentlemen and welcome to the King Pharmaceuticals First Quarter Year 2010 Financial Results Conference Call. All lines have been placed on a listen-only mode and the floor will be opened for your questions and comments following the presentation. (Operator Instructions).
-
King Pharmaceuticals , Inc. KG Q2 2010 Earnings Call Transcript
Good morning, ladies and gentlemen and welcome to the King Pharmaceuticals' Second Quarter Year 2010 Financial Results Conference Call. All lines have been placed in a listen-only mode and the floor will be opened for your questions and comments following the presentation.
-
Stock Star Rating Performance Update
As 2005 draws to a close, our performance continues to be solid all around, with some bright spots and a few areas for further improvement. Our contrarian stance on large-cap and energy stocks has weighed on our results recently, but we're still confident that those calls will work out in the end. ...
-
Our Take on IPO Cumberland's Growth Prospects
Health-care analyst Brian Laegeler likes the fact that specialty pharma IPO Cumberland is already profitable, but a weak pipeline and a pricey offer price are concerns.
-
Morningstar Investment Conference
June 12-14, 2013
Chicago, IL
Conference hashtag: #MIC25 -
Morningstar ETF Invest Conference
Oct. 2-4, 2013
Chicago, IL
Conference hashtag: #ETFInvest
-
Real Assets to the Rescue
Tuesday, April 9
11:00 a.m. ET | 10:00 a.m. CT -
The Hunt for Income
Tuesday, January 29
11:00 a.m. ET | 10:00 a.m. CT -
Introduction to ETF Managed Portfolios
Monday, December 10
4:00 p.m. ET | 3:00 p.m. CT -
Using ETFs for Income
Aired on Tuesday, June 12 - Archive
